Loading company…
Riskpilot
← Back to search
Sign in
Get full access
GREVERUD APOTEK AS
AS
Active
Org 924379812
Flåtestadveien 3, 1415 Oppegård
Retail sale of pharmaceutical products · NACE 4773
Est. 2020
16 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
NOK 32,2M
+5% vs 2022
EBITDA margin
4.1%
+181% vs 2022
Equity ratio
7.8%
Financial strength
Net profit 2023
NOK 914K
+162% vs 2022
EBITDA — year on year
NOK millions
3M
1M
0M
-1M
-3M
2M
2021
-2M
-200%
2022
1M
+150%
2023
Key figures
Annual report 2023
Revenue
NOK 32,2M
+5%
EBITDA
NOK 1,3M
+181%
Net profit
NOK 914K
+162%
Total assets
NOK 7,2M
+66%
Equity
NOK 562K
+259%
Employees
16
—
Company information
Legal name
GREVERUD APOTEK AS
Org number
924379812
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
9. januar 2020
Share capital
NOK 30 000
Employees
16 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-01-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder hver for seg.
Company purpose
Butikkhandel med apotekvarer.
Contact
Address
Flåtestadveien 3, 1415 Oppegård
Phone
+4741117830
Email
maher.salameh@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Nordre Follo
All Norway companies
Revenue
NOK millions
0M
9M
18M
28M
37M
18M
2021
31M
2022
32M
2023
EBITDA
NOK millions
0M
1M
1M
2M
2M
2M
2021
-2M
2022
1M
2023
Income statement
NOK thousands
Item
2021
2022
2023
Revenue
18 384
30 524
32 163
Staff expenses
−2 154
−4 018
−3 576
EBITDA
1 524
−1 654
1 334
Depreciation & amort.
−104
−128
−128
EBIT
1 420
−1 781
1 207
Net financials
−26
6
−5
Profit before tax
1 393
−1 776
1 202
Tax
307
−307
287
Net profit
1 086
−1 469
914
Balance sheet
NOK thousands
Item
2021
2022
2023
Total assets
6 490
4 353
7 242
Equity
1 116
−352
562
Long-term debt
20
0
0
Short-term debt
5 354
4 705
6 681
Total debt
5 374
4 705
6 681
Financial ratios
5-year trend
EBITDA margin
4.1%
This company
15.8%
Market median
-74% vs market
2021
2023
Equity ratio
7.8%
This company
38.2%
Market median
-80% vs market
2021
2023
Return on equity
162.7%
This company
18.4%
Market median
+784% vs market
2021
2023
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
2021
2023
Asset turnover
4.44×
This company
1.12×
Market median
+296% vs market
2021
2023
Debt / equity
11.89×
This company
0.62×
Market median
-1818% vs market
2021
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-02-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-02-01 – 2022-01-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2019-12-14 – 2021-01-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
BM
Børge Moholt
Chairman
2023
ØA
Øystein Askim
Board of Directors
2023
Former (1)
MA
Maher Ayman Salameh
Chairman
2020 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Apotek 1 Gruppen As
Company
100%
100%
2023
Scandic Inv As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Scandic Inv As
GREVERUD APOTEK AS
(this company)
Board network connections
Board members of GREVERUD APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Maher Ayman Salameh
Chairman
0 companies
Børge Moholt
Chairman
0 companies
Øystein Askim
Board of Directors
0 companies